Le Lézard
Classified in: Health, Covid-19 virus
Subject: CPG

COVID-19 Pandemic - The government presents its daily update


QUÉBEC CITY, Sept. 17, 2020 /CNW Telbec/ - The most recent data on the evolution of COVID-19 in Québec show 251 new cases, bringing the total number of people infected to 66,356. Also, 2 deaths have occurred in the last 24 hours, to which is added 1 death which has occurred between September 10 and September 15, for a total of 5,791. The number of hospitalizations increased by 6 compared to the previous day, for a cumulative total of 136. Among these, the number of people in intensive care increased by 3, for a total of 29. The samples conducted on September 15 amount to 24,112 for a total of 1,979,527.

Summary Data Evolution Table

Date

Confirmed
cases

Deaths

Hospitalizations

Hospitalizations
in intensive
care

Tests
performed

September 10

221

(addition :
2)*

0 + 1*

*Date
unknown

123

(+4)

12

25,962

September 11

269

(addition :
25)*

0

125

(+2)

16

(+4)

21,132

September 12

310

(addition :
31)*

2

124

(-1)

19

(+3)

20,639

September 13

372

(addition :
96)*

3

124

19

21,500

September 14

382

(addition :
90)*

2

133

(+9)

23

(+4)

22,568

September 15

303

2

130

(-3)

26

(+3)

24,112

September 16

251

2

136

(+6)

29

(+3)

NA

* As announced on Thursday morning by the Montréal public health authorities, 248 cases were added between September 9 and September 14 due to a catch-up in the entry of laboratory results.

Note that the majority of data are presented according to the day they were entered. They are extracted at 4 p.m. at the date shown and cover the preceding 24 hours. However, the availability of the data on samples involves an additional delay of 24 hours and these correspond to the number of samples taken on the date shown. It should also be noted that the data prior to those of the last 24 hours presented in the column of deaths have been adjusted according to the actual dates of death. This explains the variation of some data compared to those presented in previous press releases. The daily death toll is influenced by the time required for the physician to report the death, the time required to complete the investigation to confirm that the death was attributable to COVID-19, and the entry into the system.

A reminder concerning public health instructions

To limit to the utmost the virus' spread, it is important to:

For people aged 10 and over, wearing a face covering is now mandatory in most enclosed and partially enclosed public places and on public transit.

Should symptoms appear:

Related links

SOURCE Ministère de la Santé et des Services sociaux


These press releases may also interest you

at 04:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it has surpassed 55 million miles driven across its range of products.Phoenix offers a range of...

at 03:45
Phoenix Motor Inc. , a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced the appointment of Michael Yung as its new Chief Financial Officer (CFO), effective April 17,...

at 02:00
Centamin plc ("Centamin", "Group" or "the Company") (LSE:CEY)QUARTERLY REPORTfor the three months ended 31 March 2024MARTIN HORGAN, CEO, commented: "The scheduled processing of lower-grade ore from the open pit,...

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...

at 01:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...



News published on and distributed by: